The CC chemokine ligand (CCL) 1, upregulated by the viral transactivator Tax, can be downregulated by minocycline: possible implications for long-term treatment of HTLV-1-associated myelopathy/tropical spastic paraparesis

[1]  E. Inoue,et al.  Effectiveness of Daily Prednisolone to Slow Progression of Human T-Lymphotropic Virus Type 1-Associated Myelopathy/Tropical Spastic Paraparesis: A Multicenter Retrospective Cohort Study , 2017, Neurotherapeutics.

[2]  Y. Yamano,et al.  HTLV-1-associated myelopathy/tropical spastic paraparesis , 2015, Nature Reviews Disease Primers.

[3]  S. Sethi,et al.  Long-term macrolide therapy in chronic obstructive pulmonary disease , 2014, Canadian Medical Association Journal.

[4]  A. Zarzuelo,et al.  Minocycline: far beyond an antibiotic , 2013, British journal of pharmacology.

[5]  D. Greaves,et al.  CC Chemokine Receptors and Chronic Inflammation—Therapeutic Opportunities and Pharmacological Challenges , 2013, Pharmacological Reviews.

[6]  Yuetsu Tanaka,et al.  Minocycline modulates antigen-specific CTL activity through inactivation of mononuclear phagocytes in patients with HTLV-I associated neurologic disease , 2012, Retrovirology.

[7]  Charles R. M. Bangham,et al.  Systems Biology Approaches Reveal a Specific Interferon-Inducible Signature in HTLV-1 Associated Myelopathy , 2012, PLoS pathogens.

[8]  S. David,et al.  Repertoire of microglial and macrophage responses after spinal cord injury , 2011, Nature Reviews Neuroscience.

[9]  Jeffrey A. Cohen,et al.  Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria , 2011, Annals of neurology.

[10]  W. Deng,et al.  Prospects for minocycline neuroprotection. , 2010, Archives of neurology.

[11]  Kousuke Saito,et al.  In vivo expression of the HBZ gene of HTLV-1 correlates with proviral load, inflammatory markers and disease severity in HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP) , 2009, Retrovirology.

[12]  M. Matsuoka,et al.  Transcriptional Control of Spliced and Unspliced Human T-Cell Leukemia Virus Type 1 bZIP Factor (HBZ) Gene , 2008, Journal of Virology.

[13]  K. Santacruz,et al.  Minocycline neuroprotects, reduces microgliosis, and inhibits caspase protease expression early after spinal cord injury , 2006, Journal of neurochemistry.

[14]  J. Brotchi,et al.  Clinical potential of minocycline for neurodegenerative disorders , 2004, Neurobiology of Disease.

[15]  Y. Oh,et al.  Minocycline reduces cell death and improves functional recovery after traumatic spinal cord injury in the rat. , 2003, Journal of neurotrauma.

[16]  D. Hussey,et al.  Minocycline: stain devil? , 2003, The British journal of dermatology.

[17]  S. Jacobson.  Immunopathogenesis of human T cell lymphotropic virus type I-associated neurologic disease. , 2002, The Journal of infectious diseases.

[18]  Dong-Kug Choi,et al.  Blockade of Microglial Activation Is Neuroprotective in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Mouse Model of Parkinson Disease , 2002, The Journal of Neuroscience.

[19]  D. Saul,et al.  Autocrine antiapoptotic stimulation of cultured adult T-cell leukemia cells by overexpression of the chemokine I-309. , 2001, Blood.

[20]  B. Fiebich,et al.  Minocycline, a Tetracycline Derivative, Is Neuroprotective against Excitotoxicity by Inhibiting Activation and Proliferation of Microglia , 2001, The Journal of Neuroscience.

[21]  S. Izumo,et al.  Analysis of HTLV-I proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM/TSP. , 1999, Journal of neurovirology.

[22]  T. Hökfelt,et al.  Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[23]  J. Meynadier,et al.  Systemic Antibiotics for Acne , 1998, Dermatology.

[24]  S. Abramson,et al.  A novel mechanism of action of tetracyclines: effects on nitric oxide synthases. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[25]  T. Fujiyoshi,et al.  Intrathecal humoral immune response in HAM/TSP in relation to HLA haplotype analysis , 1996, Acta neurologica Scandinavica.

[26]  Y. Itoyama,et al.  Interferon-alpha is effective in HTLV-I-associated myelopathy , 1996, Neurology.

[27]  O. Yoshie,et al.  Constitutive expression of various chemokine genes in human T‐cell lines infected with human T‐cell leukemia virus type 1: Role of the viral transactivator Tax , 1996, International journal of cancer.

[28]  M. Krangel,et al.  The human cytokine I-309 is a monocyte chemoattractant. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[29]  T. Walczak,et al.  Neopterin in cerebrospinal fluid , 1991, Neurology.

[30]  K. Sugamura,et al.  Activation of endogenous c-fos proto-oncogene expression by human T-cell leukemia virus type I-encoded p40tax protein in the human T-cell line, Jurkat , 1989, Journal of virology.

[31]  Mitsuhiro Osame,et al.  HTLV-I ASSOCIATED MYELOPATHY, A NEW CLINICAL ENTITY , 1986, The Lancet.

[32]  F. Barin,et al.  ANTIBODIES TO HUMAN T-LYMPHOTROPIC VIRUS TYPE-I IN PATIENTS WITH TROPICAL SPASTIC PARAPARESIS , 1985, The Lancet.

[33]  K. Yamaguchi,et al.  Monoclonal integration of human T-cell leukemia provirus in all primary tumors of adult T-cell leukemia suggests causative role of human T-cell leukemia virus in the disease. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[34]  R. Ferguson,et al.  LYMPHOID CELLS IN JEJUNAL MUCOSA , 1975, The Lancet.

[35]  R. Nau,et al.  Immunomodulatory properties of antibiotics. , 2008, Current molecular pharmacology.

[36]  M. Osame.  [HTLV-I-associated myelopathy]. , 1999, Ryoikibetsu shokogun shirizu.

[37]  K. Arimura,et al.  Therapeutic trials in 200 patients with HTLV-I-associated myelopathy/ tropical spastic paraparesis. , 1996, Journal of neurovirology.

[38]  K. Arimura,et al.  HTLV-I-associated myelopathy: analysis of 213 patients based on clinical features and laboratory findings. , 1995, Journal of neurovirology.

[39]  H. Towler,et al.  Adult T-cell leukemia : antigen in an ATL cell line and detection of antibodies to the antigen in human sera , 2022 .